Navigation Links
Scientists win funding to study new treatment for severe chronic pain
Date:11/21/2012

Scientists at the University of Liverpool are leading a 1.5 million project to study `immunoglobulin', a type of drug which has been shown to ease complex regional pain syndrome (CRPS).

The team, from the University of Liverpool and the Walton Centre, who have already conducted previous work with this drug type, will now trial `immunoglobulin' in a larger group of patients who have suffered from CRPS for between one and five years. The Medical Research Council (MRC)-funded study will start to recruit patients in March 2013 and results are expected to be published in 2016/17.

Dr Andres Goebel, from the Institute of Translational Medicine who is leading the study, said: "The immunoglobulin technology is an entirely new way of treating severe chronic pain. It may help people with CRPS whose pain was previously virtually untreatable.

"This is also a sign of recognition, by one of the most prestigious research funding bodies in the UK, of the value of developing novel ways of treating patients with chronic pain, which causes such a burden in the general population.

"Using immunoglobulin treatment at a low dose (0.5g/kg) has very few side effects. We hope that we will eventually be able to demonstrate that this treatment is good value for money, and that it can be introduced into NHS practice, although additional studies will be required to achieve that goal."

CRPS is an unexplained condition that usually develops after an injury or trauma to a limb, and continues after the injury has healed. CPRS I, formerly called Reflex Sympathetic Dystrophy, can arise after any type of injury. CRPS II, previously called causalgia (a term coined in the American Civil War when it was first diagnosed), follows partial damage to a nerve.

In some cases the pain can be so severe that patients request amputation, only to find that the pain returns in the stump. CRPS pain can improve within one year after the injury, but if it is still unchanged after 12 months (longstanding CRPS), then it will often not improve at all. Longstanding CRPS affects about 1 in 2,000 people in the UK. More follows


'/>"/>
Contact: Sarah Stamper
sarah.stamper@liv.ac.uk
01-517-943-044
University of Liverpool
Source:Eurekalert

Related medicine news :

1. A*STAR scientists identify potential drug target for inflammatory diseases including cancers
2. Scientists at Mainz University identify inhibitor of myelin formation in the central nervous system
3. Scientists Track Activity in Rappers Brains
4. Scientists ID Gene Mutation That May Triple Alzheimers Risk
5. Kessler Foundation scientists report negative impact of long-term caregiving on cognition
6. John Templeton Foundation grant supports Princeton neuroscientists to study cognitive control
7. Scientists discover how stomach cancer spreads
8. How do cells tell time? Scientists develop single-cell imaging to watch the cell clock
9. Scientists Find Gene Differences in Nonsmokers With Lung Cancer
10. Scientists at IRB BARCELONA discover a key process that allows colon cancer to metastasize
11. Scientists uncover a new pathway that regulates information processing in the brain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... ... December 06, 2016 , ... METTLER TOLEDO has launched its ... including white papers, guides, handbooks, case studies, magazines, webinars, videos, catalogs, brochures, datasheets, ... 9,000 documents, webinars and videos available online, visit the METTLER TOLEDO Expertise ...
(Date:12/6/2016)... ... , ... “Tatiana Sibirskaya: A Life Devoted to Performing God’s ... enlightenment. , “Tatiana Sibirskaya: A Life Devoted to Performing God’s Miracles” ... Carolyn gravitated toward writing through the inspiration of her aging parents. Determined to ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... magazine’s 2017 Training Top 125 for their industry leading training methods that engage ... recognizes USA as among the global elite in employer-sponsored training and development programs. ...
(Date:12/5/2016)... (PRWEB) , ... December 06, 2016 , ... For many ... Lithuanian poetry , both thick and thin. The beauty of the Lithuanian language ... Trafford Publishing). , In this poetry book, Zubinas lyrically explores all aspects of a ...
(Date:12/5/2016)... ... ... “Epilepsy Awareness,” which can be found at the American ... epilepsy, bearing down on the social stigma and lack of public education surrounding ... their lifetime. With such a large percentage of people affected, it’s critically important ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... BOCA RATON, Fla. , Dec. 5, ... Commercialization of Public Research (the Florida Institute) ... agreement SegAna, LLC, an Orlando ... Central Florida. The Florida Institute supports new company ... funding gaps for companies spinning out of Florida-based universities ...
(Date:12/5/2016)... 2016  Breckenridge Pharmaceutical, Inc. announced today that ... with development and manufacturing partner Gland Pharma Limited ... of this agreement, Breckenridge will market and distribute ... the United States . The deal includes ... products cover a wide range of indications.  This ...
(Date:12/5/2016)... Mich. , Dec. 5, 2016  Sharn Anesthesia ... preferred anesthesia sales and distribution partner for Salter Labs.  ... of the Year in recognition of outstanding sales performance. ... devices for respiratory and anesthesia care, including the market ... is also the master distributor of the Parker Flex-Tip® ...
Breaking Medicine Technology: